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ABSTRACT: The highly regio- and enantioselective (up
to >99:1 dr, up to 99:1 er) desymmetrization of meso-1,4-
dibromocycloalk-2-enes using asymmetric allylic substitu-
tion with organolithium reagents to aﬀord enantioenriched
bromocycloalkenes (ring size of 5 to 7) has been achieved.
The cycloheptene products undergo an unusual ring
contraction. The synthetic versatility of this Cu(I)-
catalyzed reaction is demonstrated by the concise
stereocontrolled preparation of cyclic amino alcohols,
which are privileged chiral structures in natural products
and pharmaceuticals and widely used in synthesis and
catalysis.
Theenantioselective desymmetrization ofmeso compounds isone of the most powerful strategies in organic synthesis.1 It
enables the formation of compounds with multiple stereocenters
in a single step from readily accessible σ-symmetric precursors. In
the case of meso-cycloalk-2-ene-1,4-diol derivatives, desymmet-
rization by asymmetric allylic substitution (AAS) is a powerful
tool for the construction of enantiomerically enriched function-
alized cyclic products,2 which have found ample use in the total
syntheses of various natural products.3 Depending on the choice
of nucleophile (soft or hard) and metal catalyst, the reaction can
result in either α- or γ-substitution, with either retention or
inversion of conﬁguration. The most commonly employed
procedure is the Pd-catalyzed desymmetrization, which is usually
performed with soft nucleophiles to give SN2 products (Scheme
1a).2,3 A viable alternative is the Rh-catalyzed desymmetrization
using arylboronic acids,4 which give SN2 or SN2′ products
depending on the ligand at Rh. These processes, albeit highly
versatile at producing chiral building blocks, rely on precious
metal catalysts. In contrast, there are markedly few examples of
the Cu(I)-catalyzed desymmetrization, which generally employs
hard nucleophiles to provide SN2′ products.5 Sawamura and co-
workers have utilized the Cu-catalyzed asymmetric boryl
substitution in conjunction with allylation to aﬀord a formal
SN2 substitution with electrophiles.
6
The Cu(I)-catalyzed AAS with organometallic nucleophiles,
pioneered by Bac̈kvall and van Koten in 1995,7 is an eﬀective
method to synthesize tertiary carbon stereocenters.8 While many
diﬀerentmetal catalysts andorganometallic nucleophiles could be
used for AAS,9 the readily available organolithium reagents were
considered too reactive tobe utilized in catalytic asymmetricC−C
bond formation until the 2011 disclosure by Feringa et al. using
allylic bromides as substrates, forming SN2′ products with high
regio- and enantioselectivities.10 In recent years our group has
extended this protocol,11 most notably to the use of allylic-
chlorides and -ethers11a,b and aryllithium nucleophiles11c,d and
also to the formation of highly challenging all-carbon quaternary
stereocenters.11b,d We envisaged that the AAS strategy with
organolithium reagents could be applied to the desymmetrization
of meso compounds. Herein, we report the highly regio- and
enantioselective (up to >99:1 dr, up to 99:1 er) desymmetrization
ofmeso-2-cycloalkene-1,4-dibromides usingCu(I)-catalyzedAAS
with organolithium reagents to aﬀord enantioenriched bromo-
cycloalkene synthons (Scheme 1b).
Optimization of the desymmetrization reaction began with
meso-3,6-dibromocyclohex-1-ene 1 as model electrophile and
commercially available n-BuLi as nucleophile in the presence of a
catalytic amount of CuBr·SMe2 and chiral ligand. The racemic
reaction with PPh3 as ligand (Table 1, entry 1) proceeded to full
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Scheme 1. Desymmetrization of meso-1,4-Cycloalkenediol
Derivatives
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conversion to give trans-4-bromo-3-butylcyclohexene 2d as the
major product (from SN2′ substitution) in 91% yield. The double
addition product 3 (9%) was also observed; its formation most
probably occurs via a SN2-type substitution followed by a SN2′-
type substitution on the allylic bromide intermediate. Taniaphos
L1, which was an eﬀective chiral ligand in the acyclic AAS,10 was
initially tested (entry 2). Unfortunately, no conversion was
observed that (based on models) was attributed to steric
interactions between L1 and cyclohexene 1. We then switched
to the phosphoramidite ligand class,12 which has previously been
used in the desymmetrization of meso-cyclic bis(diethyl
phosphates) by Cu-AAS using organozinc reagents.5b,c With
(S,R,R)-phosphoramidite L2, only partial conversion was
observed, and the desired product had low er (entry 3). When
(S,S,S)-phosphoramiditeL3was tested, 90%conversion (98:2 er)
to the desired product was found (entry 4). When this
transformation was performed on multigram scale, analytically
pure 2d was obtained in 89% yield and 99:1 er. Neither a more
electron-rich phosphoramidite L4 nor a more ﬂexible octahy-
drophosphoramidite L5 could enhance this result (entries 5 and
6).When a 9:1 cis/transmixture of startingmaterial was subjected
to the optimized conditions with L3, the enantioselectivity was
maintained (99:1 er), and the product 2d could be isolated in 80%
yield (entry 7); trans-1 was almost entirely recovered. This
prompted us to investigate the reaction with racemic trans-1
under the same conditions (entry 8). Unsurprisingly, the reaction
did not proceed to full conversion, and formation of some cis-4-
bromo-3-butylcyclohex-1-ene 4 was also observed. The absolute
conﬁguration of 2d was determined by X-ray crystallography of
diol 5 (Table 1, inset),13 resulting in a Flack parameter of x =
0.04(2). Chiral HPLC conﬁrmed that a single diastereomer of 5
with four contiguous stereocenters was obtained (>99:1 dr, 99:1
er) after Upjohn dihydroxylation of 2d.
With the optimized conditions in hand (entry 4), we proceeded
to examine the scope of the reaction. Continuing with the six-
membered substrate 1 (Scheme 2), the addition of commercially
available alkyllithium reagents aﬀorded the AAS products 2a−e
with excellent enantioselectivities (up to 99:1 er).Only isopropyl-
bearing product 2c had a slightly lower er (95:5), possibly a result
of the steric bulk of the isopropyl group. The reaction worked
similarly well for meso-3,5-dibromocyclopentene 6 to generate
products 7a−e in good yields with up to 96:4 er (Scheme 2).
When meso-3,7-dibromo-cycloheptene 8 was used in the
desymmetrization reaction with alkyllithium reagents (Scheme
3), the expected products 9a−e (>99:1 dr) were initially obtained
with er values ranging from 90:10 to 97:3, based on NMR and
chiral GC. However, when puriﬁcation of these seven-membered
rings 9a−e was attempted by ﬂash column chromatography on
silica, only their corresponding cyclohexene analogs 10a−e were
isolated with complete stereospeciﬁcity. A detailed structural
Table 1. Screening of Ligands for AAS-Desymmetrization of
meso-Dibromocyclohexene 1 with n-BuLia
aConditions: meso-1 (0.2 mmol) in CH2Cl2 (2 mL). n-BuLi (0.24
mmol, 1.6 M solution in hexanes diluted to a ﬁnal concentration of
0.24 M) was added over 2 h. bDetermined by GC−MS and 1H NMR.
cer determined by chiral GC. dA 9:1 cis/trans mixture of 1 was used.
eIsolated yield of 2d on 0.2 mmol scale; increases to 89% on 10 mmol
scale (see SI). fRacemic trans-1 was used. Inset: Ball-and-stick
representation of the X-ray crystal structure of diol 5.
Scheme 2. Alkyllithium Scope for Desymmetrization of Five-
andSix-Memberedmeso-CyclicAllylicDibromides 1 and6a,b,c
aConditions: meso-1 (9:1 cis/trans) or 6 (0.2 mmol) in CH2Cl2 (2
mL). RLi (0.24 mmol, diluted to a ﬁnal concentration of 0.24 M) was
added over 2 h. bIsolated yields. cer determined by chiral GC. dGC
yields reported due to product volatility (see SI).
Scheme 3. Desymmetrization-Rearrangement of Seven-
Membered meso-Cyclic Allylic Dibromide 8a,b,c
aConditions: (i) meso-8 in CH2Cl2 (2 mL). RLi (0.24 mmol, diluted to
a ﬁnal concentration of 0.24 M) was added over 2 h; (ii) silica,
pentane. bIsolated yields. cer of 9a−e and 10a−e determined by chiral
GC to be the same, so enantiospeciﬁcity > 99%.
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analysis and mechanistic and theoretical study to elucidate this
remarkable ring contraction are reported separately.14
We hypothesized that a phenyl substituent would stabilize the
desymmetrization product, i.e., chiral cycloheptene 9, enabling its
isolation. We have previously reported that N-heterocyclic
carbenes (NHC) are themost suitable ligand class for asymmetric
allylic arylation (AAAr).11c,d As such, we screened, besides achiral
L6 as control, several chiral NHC ligands for the desymmetriza-
tion of dibromocycloheptene 8 with phenyllithium (Table 2).
While the dihydroimidazolium-based ligands L7 and L8 gave
excellent conversion, the er was poor to moderate (entries 2 and
3). In contrast, triazolium-based ligands L9 and L10 gave poorer
conversions (entries 4 and 5). Gratifyingly, we found that
imidazolium salt L12 was a suitable NHC precursor; in
conjunction with CuBr·SMe2 and NaOt-Bu, this catalytic system
aﬀorded the desired 4-bromo-3-phenylcycloheptene 9f in 83%
isolated yield with 95:5 er (entry 7). In accordance with our
prediction, and in sharp contrast with alkyl analogs 9a−e, this
productwas stable to base-treated silica and could be isolated.The
absolute conﬁguration of 9fwas determined to be (R,R) by X-ray
crystallography of diol 11 (Table 2, inset),15 which was obtained
via diastereoselective Upjohn dihydroxylation (88:12 dr, 96:4 er
as determined by chiral HPLC).
Cyclic amino alcohols are structural elements found in
numerous natural products, e.g., tropane alkaloids,16 and are
privileged scaﬀolds in medicinal chemistry, e.g., atropine and
cocaine.18 Having access to a variety of enantioenriched
bromocycloalkenes of various ring sizes via the AAS-desymmet-
rization protocol, we next demonstrated the versatility of these
products by the concise stereocontrolled synthesis of cyclic amino
alcohols (Scheme 4). Reaction of cyclohexene 2d with m-CPBA
aﬀorded a 71:29 diastereomeric mixture of epoxides. Ring
opening of the epoxide with benzylamine catalyzed by silica
under neat conditions was selective for the major epoxide isomer,
aﬀording trans-1,2-aminoalcohol derivative 12 in 60% yield over
two steps. SN2 substitution of bromide 12 with sodium azide
followed by hydrogenation yielded trans-1,4-diamino-2-alcohol
13 with four contiguous stereocenters (Scheme 4a). The seven-
membered analog cycloheptene 9f undergoes diastereoselective
Upjohn dihydroxylation (88:12 dr) to aﬀord cis-1,2-diol 11 in
80% yield, which was readily transformed into aminodiol 14 via
substitution and hydrogenation (Scheme 4b).
Aminodiol 14 is a direct precursor to 2-phenyl-tropan-6α-ol
using the cyclization strategy described by Pollini et al.17 These 8-
azabicyclo[3.2.1]octanes18 represent an important scaﬀold of
bioactive tropane alkaloid natural products such as schizanthines,
baogongtengs, and calystegines.16b,19 Thus, our synthesis of
aminodiol 14 represents an eﬃcient route to phenyl-substituted
analogs of these natural products and drug targets (see Figure 1).
In summary, the highly regio- and enantioselective desymmet-
rization ofmeso-dibromocycloalkenes with ring size ranging from
5 to 7 via Cu-AAS with organolithium reagents has been
demonstrated. Phosphoramidite L3 is the preferred ligand for
alkyllithium reagents, while for arylation NHC was found to be
the ligand of choice. These ﬁndings represent an eﬃcient method
to access enantioenriched cyclic bromoalkenes; the synthetic
utility of the products is demonstrated by the concise synthesis of
Table 2. Screening of Ligands for AAAr-Desymmetrization of
meso-Dibromocycloheptene 8 with PhLia
aConditions: meso-8 (0.2 mmol) in CH2Cl2 (2 mL). PhLi (0.30 mmol,
1.9 M solution in di-n-butyl ether diluted with hexanes to a ﬁnal
concentration of 0.30 M) was added over 2 h. bDetermined by GC−
MS and 1H NMR. cer determined by chiral GC. dIsolated yield of 9f.
Inset: Ball-and-stick representation of the X-ray structure of diol 11.
Scheme 4. Derivatization of Desymmetrization Products
Towards Cyclic Aminoalcoholsa
aConditions: (i) m-CPBA (1.2 equiv), PhMe, RT; (ii) BnNH2 (1.2
equiv), silica (10 wt %), 80 °C; (iii) NaN3 (3 equiv), DMF, 80 °C; (iv)
H2 (1 atm), Pd/C (20 mol %), EtOAc; (v) OsO4 (4 mol %), NMO
(1.5 equiv), acetone/H2O (3:1).
Figure 1. Examples of tropane alkaloids with the 8-azabicyclo[3.2.1]-
octane framework.
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chiralmultifunctional cyclic aminoalcohols, which are a privileged
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